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A Propensity-matched Analysis of Outcomes for Patients with M2 Branch Occlusions at Endovascular 
Stroke Centers 
Ovando, R. Lucas, L., Baraban, E., Tarpley, J. 
 
Title: A propensity-matched analysis of outcomes for patients with M2 branch occlusions at 
endovascular stroke centers 
Introduction: Endovascular therapy (EVT) for Emergent Large Vessel Occlusion (ELVO) is recommended 
for patients with acute proximal MCA (M1 segment) occlusions (Class I, level A evidence), but the 
benefits of EVT are uncertain in patients with M2 and more distal occlusions. The purpose of this study 
was to compare the efficacy and outcomes of EVT-treated M2 ELVOs with EVT-treated M1 ELVOs, and to 
examine the outcomes of EVT-treated M2 ELVO patients with those whose M2 ELVOs were not treated. 
Methods: Data were obtained from a multi-hospital system of patients from January 2014 and May 
2018. Two propensity score (PS)-based nearest-neighbor matching analyses were used to match similar 
patients who had 1) EVT-treated M1 vs EVT-treated M2 ELVOs and 2) EVT-treated vs non-EVT-treated 
M2 ELVOs. Outcomes included length of stay (LOS), rate of successful reperfusion, discharge disposition, 
symptomatic intracranial hemorrhage (sICH), and discharge mRS. Chi-squared, Fisher’s exact, and Mann-
Whitney U tests were used to compare matched patients. Results: Overall, 160 patients with EVT-
treated M2 ELVOs, 350 with EVT-treated M1 ELVOs, and 113 with non-EVT-treated M2 ELVOs were 
included. Propensity score analyses resulted in 118 matched patients with EVT-treated M2 and EVT-
treated M1 occlusions and 70 matched patients with EVT-treated and non-EVT-treated M2 ELVOs. M2 
ELVOs made up 20% of all LVO patients. Treated M1 and M2 ELVOs were similar with respect to baseline 
NIHSS and outcomes. When attempted,intra-arterial reperfusion of M2 ELVOs was achieved at 
comparable rates to M1 ELVOs with equal rates of sICH (1.7%). Higher NIHSS was associated with EVT of 
M2 ELVOs (15.00[8.50,21.00] vs 7.00[4.00,17.75]; p<0.001). Rates of mortality trended more favorably 
in treated M2 ELVOs (12.9% vs 20), which was not statistically significant (p=0.362). Conclusions: EVT for 
M2 ELVOs is as safe and effective as EVT for M1 vessel ELVOs. Rates of successful reperfusion, discharge 
mRS, LOS, sICH, discharge disposition and mortality are similar among EVT treated M2 and EVT treated 
M1 ELVOs. Though not statistically significant, EVT for patients with M2 ELVOs resulted in favorable 
trends toward higher survival rates of potential clinical significance. 
 
